Skip to content

Clinical and Biological Outcomes of Human Milk and Formula Intake After Gastroschisis Repair

Clinical and Biological Outcomes of Human Milk and Formula Intake After Gastroschisis Repair

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02575846
Enrollment
4
Registered
2015-10-15
Start date
2015-11-26
Completion date
2016-11-11
Last updated
2024-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroschisis

Brief summary

The purpose of this study is to determine which type of food results in a shorter hospital stay and better overall outcome for babies born with gastroschisis.

Interventions

DIETARY_SUPPLEMENTEnteral Intake - Human Milk

Comparing formula and human milk

DIETARY_SUPPLEMENTEnteral Intake - Formula

Comparing formula and human milk

Sponsors

Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
2 Hours to 48 Hours
Healthy volunteers
Yes

Inclusion criteria

* 1\) neonates born with gastroschisis * 2\) neonatologist, surgeon, and parent (or care provider) willing to have the neonate participate in the study

Exclusion criteria

* 1\) associated anomaly or medical concern that impacts hospital length of stay (i.e. intestinal atresia, very low birth weight(\<1500 grams)) * 2\) known major chromosomal abnormality

Design outcomes

Primary

MeasureTime frame
Length of Hospital StayOne month

Secondary

MeasureTime frame
Time to Full Enteral FeedsThree weeks
Time on Total Parenteral NutritionThree weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026